Antibacterial Effects of Aqueous Extract of Moringa Oleifera Leaves on Methicillin-Resistant <i>Staphylococcus Aureus</i>: Research Article
PDF

Keywords

Broth micro dilution, Crude extraction, Kirby-Bauer disc diffusion, Maceration, Moringa oleifera

How to Cite

Antibacterial Effects of Aqueous Extract of Moringa Oleifera Leaves on Methicillin-Resistant Staphylococcus Aureus: Research Article. (2025). Pak-Euro Journal of Medical and Life Sciences, 8(3), 593-600. https://doi.org/10.31580/t04k5a83

Abstract

The primary objective was to investigate the potential antibacterial efficacy of Moringa oleifera against Methicillin-resistant Staphylococcus aureus (MRSA). A well-known medicinal plant valued for its nutritional benefits. Given the escalating challenge of antibacterial resistance, there is a pressing need to explore alternative treatments, thus providing impetus for this investigation. The antibacterial effects of aqueous Moringa oleifera leaf extract at concentrations of 6.25, 12.5, 25, 50, 100, 200, and 400 mg/ml were tested against MRSA using the standardized broth microdilution technique and a confirmatory modified disc diffusion method. Strains of MRSA were isolated from blood, wound and pus swabs, sputum, urine, cerebro-spinal fluid and synovial fluid. The broth microdilution method revealed mean inhibitions of 34.3% (1.5) at 25 mg/ml and 10.7% (0.3). The disc diffusion method indicated inhibitory zones of 14 mm, 13 mm, 12 mm, 10 mm, and 9 mm at concentrations of 200 mg/ml, 100 mg/ml, 50 mg/ml, and 25 mg/ml, respectively. The inhibition zones demonstrate a proportional increase with the rising concentration of the extract, confirming a direct correlation. No effective inhibition or zone formation was observed at 6.25 mg/ml. The minimum inhibitory concentration determined by both techniques concurred at 12.5 mg/ml.

PDF

References

1. Fahey JW. Moringa oleifera: a review of the medical evidence for its nutritional, therapeutic, and prophylactic properties. Part 1. Trees for life Journal. 2005;1(5):1-15.

2. Oyeyinka AT, Oyeyinka SA. Moringa oleifera as a food fortificant: Recent trends and prospects. Journal of the Saudi Society of Agricultural Sciences. 2018;17(2):127-36.

3. Dhakad AK, Ikram M, Sharma S, Khan S, Pandey VV, Singh A. Biological, nutritional, and therapeutic significance of Moringa oleifera Lam. Phytotherapy Research. 2019;33:2870-903.

4. Bhattacharya A, Tiwari P, Sahu PK, Kumar S. A reviewof the phytochemical and pharmacological characteristics of Moringa oleifera. Journal of Pharmacy and Bioallied Sciences. 2018;10(4):181-91.

5. Onsare J, Arora D. Antibiofilm potential of flavonoids extracted from Moringa oleifera seed coat against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans. Journal of applied microbiology. 2015;118(2):313-25.

6. Iwetan BB, Okwu MU, Enwa FO. Antibacterial Effect of Aqueous and Ethanol Extracts of Moringa oleifera Leaves on Methicillin Resistant Staphylococcus aureus (MRSA) Isolates obtained from a University Community: Antibacterial Effect of Moringa oleifera leaves on MRSA. International Pharmacy Acta. 2023;6(1):e3:1-6.

7. Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century—a clinical super-challenge. New England Journal of Medicine. 2009;360(5):439-43.

Kateete DP, Bwanga F, Seni J, Mayanja R, Kigozi E, Mujuni B. CA-MRSA and HA-MRSA coexist in community and hospital settings in Uganda. Antimicrobial Resistance & Infection Control. 2019;8:1-9.

8. McCaig LF, McDonald LC, Mandal S, Jernigan DB. Staphylococcus aureus–associated skin and soft tissue infections in ambulatory care. Emerging infectious diseases. 2006;12(11):1715.

9. Nascente PdS, Meinerz ARM, Faria ROd, Schuch LFD, Meireles MCA, Mello JRBd. CLSI broth microdilution method for testing susceptibility of Malasseziapachydermatis to thiabendazole. Brazilian Journal of Microbiology. 2009;40:222-6.

10. Razzak A, Roy K, Sadia U, Mominul H, Suvro T, Sikder M. Effect of drying condition on physicochemical and antioxidant properties of dried moringa leaf powder. Food Research. 2021;5(6):165-71.

11. Shikov AN, Mikhailovskaya IY, Narkevich IA, Flisyuk EV, Pozharitskaya ON. Methods of extraction of medicinal plants. Evidence-Based Validation of Herbal Medicine: Elsevier; 2022:771-96.

12. Sanraj S, Sivasinthujah S, Gnanakarunyan T. In vitro screening of antioxidant and antibacterial activities of different solvent extracts of leaf of Mimosa pudica against selected bacteria. 2022.

13. Fernandes CJ, Fernandes LA, Collignon P. Cefoxitin resistance as a surrogate marker for the detection of methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 2005;55(4):506-10.

14. Wayne P. Clinical and laboratory standards institute; 2007. Performance standards for antimicrobial susceptibility testing CLSI document M100-S17. 2005.

15. Rodriguez JR, Hsieh F, Huang CT, Tsai TJ, Chen C, Cheng MH. Clinical features, microbiological epidemiology and recommendations for management of cellulitis in extremity lymphedema. Journal of surgical oncology. 2020;121(1):25-36.

16. Gajdács M, Ábrók M, Lázár A, Burián K. Increasing relevance of Gram-positive cocci in urinary tract infections: a 10-year analysis of their prevalence and resistance trends. Scientific reports. 2020;10(1):17658.

17. Stanaway S, Johnson D, Moulik P, Gill G. Methicillin-resistant Staphyloccocus aureus (MRSA) isolation from diabetic foot ulcers correlates with nasal MRSA carriage. Diabetes research and clinical practice. 2007;75(1):47-50.

18. Meo SA, Zia I, Bukhari IA, Arain SA. Type 2 diabetes mellitus in Pakistan: Current prevalence and future forecast. JPMA The Journal of the Pakistan Medical Association. 2016;66(12):1637-42.

19. Akhter E, Bilal S, Haque U. Prevalence of arthritis in India and Pakistan: a review. Rheumatology international. 2011;31:849-55.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2025 Pak-Euro Journal of Medical and Life Sciences